Kugaya A - Search Results

1

Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder.

Fujita M, Southwick SM, Denucci CC, Zoghbi SS, Dillon MS, Baldwin RM, Bozkurt A, Kugaya A, Verhoeff NP, Seibyl JP, Innis RB. Fujita M, et al. Among authors: kugaya a. Biol Psychiatry. 2004 Jul 15;56(2):95-100. doi: 10.1016/j.biopsych.2004.03.010. Biol Psychiatry. 2004. PMID: 15231441 Clinical Trial.

2

Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.

Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, Garg PK, Seibyl JP, Innis RB. Kugaya A, et al. Am J Psychiatry. 2003 Aug;160(8):1522-4. doi: 10.1176/appi.ajp.160.8.1522. Am J Psychiatry. 2003. PMID: 12900319 Clinical Trial.

3

Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT.

Kugaya A, Sanacora G, Verhoeff NP, Fujita M, Mason GF, Seneca NM, Bozkurt A, Khan SA, Anand A, Degen K, Charney DS, Zoghbi SS, Baldwin RM, Seibyl JP, Innis RB. Kugaya A, et al. Biol Psychiatry. 2003 Oct 15;54(8):792-9. doi: 10.1016/s0006-3223(02)01788-2. Biol Psychiatry. 2003. PMID: 14550678

4

Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.

Kugaya A, Sanacora G, Staley JK, Malison RT, Bozkurt A, Khan S, Anand A, Van Dyck CH, Baldwin RM, Seibyl JP, Charney D, Innis RB. Kugaya A, et al. Biol Psychiatry. 2004 Oct 1;56(7):497-502. doi: 10.1016/j.biopsych.2004.07.001. Biol Psychiatry. 2004. PMID: 15450785 Clinical Trial.

5

Sex differences in diencephalon serotonin transporter availability in major depression.

Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM, Vythilingam M, Kugaya A, Baldwin RM, Seibyl JP, Charney D, Innis RB. Staley JK, et al. Among authors: kugaya a. Biol Psychiatry. 2006 Jan 1;59(1):40-7. doi: 10.1016/j.biopsych.2005.06.012. Epub 2005 Sep 1. Biol Psychiatry. 2006. PMID: 16139815

6

Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.

Kugaya A, Fujita M, Innis RB. Kugaya A, et al. Ann Nucl Med. 2000 Feb;14(1):1-9. doi: 10.1007/BF02990472. Ann Nucl Med. 2000. PMID: 10770574 Review.

7

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration.

Kugaya A, Seneca NM, Snyder PJ, Williams SA, Malison RT, Baldwin RM, Seibyl JP, Innis RB. Kugaya A, et al. Neuropsychopharmacology. 2003 Feb;28(2):413-20. doi: 10.1038/sj.npp.1300036. Epub 2002 Jul 19. Neuropsychopharmacology. 2003. PMID: 12589396 Clinical Trial.

8

Lack of association between suicidal ideation and enhanced platelet 5-HT2A receptor-mediated calcium mobilization in cancer patients with depression.

Uchitomi Y, Kugaya A, Akechi T, Nakano T, Inagaki M, Matsuoka Y, Kagaya A, Yamawaki S. Uchitomi Y, et al. Among authors: kugaya a. Biol Psychiatry. 2002 Dec 15;52(12):1159-65. doi: 10.1016/s0006-3223(02)01420-8. Biol Psychiatry. 2002. PMID: 12488061

9

Beyond monoamines: glutamatergic function in mood disorders.

Kugaya A, Sanacora G. Kugaya A, et al. CNS Spectr. 2005 Oct;10(10):808-19. doi: 10.1017/s1092852900010403. CNS Spectr. 2005. PMID: 16400244 Review.

10

Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.

Sanacora G, Berman RM, Cappiello A, Oren DA, Kugaya A, Liu N, Gueorguieva R, Fasula D, Charney DS. Sanacora G, et al. Among authors: kugaya a. Neuropsychopharmacology. 2004 Jun;29(6):1166-71. doi: 10.1038/sj.npp.1300418. Neuropsychopharmacology. 2004. PMID: 15010697 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters